(February 22, 2021) France's Sanofi to help Johnson & Johnson manufacture COVID-19 vaccine
French healthcare company Sanofi SASY.PA will provide COVID-19 vaccine manufacturing
support to U.S. peer Johnson & Johnson JNJ.N, Sanofi said on Monday.
Once authorized, Sanofi will provide Johnson & Johnson access to the established infrastructure
and expertise of its vaccine manufacturing plant in Marcy l'Etoile, France,
to formulate and fill vials of Johnson & Johnson's Janssen COVID-19 vaccine candidate in 2021
at a rate of approximately 12 million doses per month.
[link to www.nasdaq.com (secure)]